Gerresheimer AG (GXI.DE)

EUR 60.55

(1.94%)

EBITDA Summary of Gerresheimer AG

  • Gerresheimer AG's latest annual EBITDA in 2023 was 400.56 Million EUR , up 7.32% from previous year.
  • Gerresheimer AG's latest quarterly EBITDA in 2024 Q3 was 101.02 Million EUR , up 3.81% from previous quarter.
  • Gerresheimer AG reported an annual EBITDA of 340.19 Million EUR in 2022, up 20.05% from previous year.
  • Gerresheimer AG reported an annual EBITDA of 293.09 Million EUR in 2021, up 0.35% from previous year.
  • Gerresheimer AG reported a quarterly EBITDA of 97.31 Million EUR for 2024 Q2, up 22.69% from previous quarter.
  • Gerresheimer AG reported a quarterly EBITDA of 101.02 Million EUR for 2024 Q3, up 3.81% from previous quarter.

Annual EBITDA Chart of Gerresheimer AG (2023 - 2005)

Historical Annual EBITDA of Gerresheimer AG (2023 - 2005)

Year EBITDA EBITDA Growth
2023 400.56 Million EUR 7.32%
2022 340.19 Million EUR 20.05%
2021 293.09 Million EUR 0.35%
2020 309.25 Million EUR 9.08%
2019 279.55 Million EUR 2.08%
2018 274.3 Million EUR -3.26%
2017 306.83 Million EUR -2.0%
2016 307.78 Million EUR 15.36%
2015 265.72 Million EUR 7.77%
2014 237.65 Million EUR 10.11%
2013 218.7 Million EUR -2.24%
2012 229.07 Million EUR 7.74%
2011 204.33 Million EUR 3.47%
2010 201.78 Million EUR 14.22%
2009 176.29 Million EUR 1.41%
2008 172.29 Million EUR 0.12%
2007 163.55 Million EUR -71.01%
2006 102.85 Million EUR 12.73%
2005 542.12 Million EUR 0.0%

Peer EBITDA Comparison of Gerresheimer AG

Name EBITDA EBITDA Difference
SCHOTT Pharma AG & Co. KGaA 227.64 Million EUR -75.961%
Carl Zeiss Meditec AG 502.77 Million EUR 20.328%
Fielmann Aktiengesellschaft 403.8 Million EUR 0.802%
Sartorius Aktiengesellschaft 920.1 Million EUR 56.465%
Sartorius Aktiengesellschaft 920.1 Million EUR 56.465%